Scrip
Market Insight - Avoiding bribery risk 1: UK focus
01 May 2009
Shaistah Akhtar
Please Login to read the full article.
01 May 2009
Shaistah Akhtar
Complex bribery laws in the UK have led to a woeful track record in prosecuting offending companies. New proposals promise much-needed reform, says Shaistah Akhtar
In a recent survey by Ernst & Young,1 33% of pharma respondents said that corrupt practices...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US SEC subpoenas Lilly in widened probe of compliance with overseas antibribery law
- South Africa to publish drug promotion breaches for first time
- Schering-Plough wins US dismissal of Intron A/Temodar off-label suit
- FDA criminal division may increase misdemeanour prosecutions against execs
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
